Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 750 of 3284 entries
View as:

National Survey on Gastroesophageal Reflux Disease (GERD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00695838 Org: User:
Start: 01/31/08 End: 12/31/08 Due: 12/31/09

AZD8330 First Time in Man in Patients With Advanced Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00454090 Org: User:
Start: 03/31/07 End: 03/31/11 Due: 03/31/12

A Study in Healthy Volunteers to Assess Safety and Blood Levels of AZD5847 After Multiple Doses Over 14 Days

Phase: N/A Priority: Normal
NCT ID: NCT01116258 Org: User:
Start: 04/30/10 End: 10/31/10 Due: 10/31/11

First-line Treatment for Adenocarcinoma Patients With Epidermal Growth Factor Receptor (EGFR) Mutation

Phase: N/A Priority: Normal
NCT ID: NCT00344773 Org: User:
Start: 03/31/06 End: 12/31/07 Due: 12/31/08

Real-world Treatment Patterns and Associated Outcomes in Patients With Resectable Early-stage Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04808050 Org: User:
Start: 11/03/21 End: 10/31/22 Due: 10/31/23

Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00256698 Org: User:
Start: 01/31/04 End: 02/29/12 Due: 02/28/13

First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT06795022 Org: User:
Start: 03/27/25 End: 07/27/28 Due: 07/27/29

An Interaction Study With Digoxin and AZD1305

Phase: N/A Priority: Normal
NCT ID: NCT00712465 Org: User:
Start: 08/31/08 End: 11/30/08 Due: 11/30/09

Exploratory Study of Coronary Flow Reserve Measurements, a Non-Invasive Method for Coronary Function Measurements

Phase: N/A Priority: Normal
NCT ID: NCT00783042 Org: User:
Start: 10/31/08 End: 05/31/09 Due: 05/31/10

Study to Compare Zoladex™ 10.8 mg With Zoladex 3.6 mg in Pre-menopausal Women With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01073865 Org: User:
Start: 02/26/10 End: 11/20/17 Due: 11/20/18

Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00259090 Org: User:
Start: 04/30/04 End: 10/31/08 Due: 10/31/09

A Study to Evaluate the Use of Mobile-phone Based Patient Support in Patients Diagnosed With Myocardial Infarction

Phase: N/A Priority: Normal
NCT ID: NCT01874262 Org: User:
Start: 06/30/13 End: 12/31/14 Due: 12/31/15

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AZD5148 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06469151 Org: User:
Start: 06/24/24 End: 11/07/25 Due: 11/07/26

Comparing Symbicort® As-Needed or Bricanyl As-Needed or Pulmicort® Once Daily + Bricanyl As-Needed in Asthma Patients

Phase: N/A Priority: Normal
NCT ID: NCT00989833 Org: User:
Start: 09/30/09 End: 07/31/10 Due: 07/31/11

A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients

Phase: N/A Priority: Normal
NCT ID: NCT00500370 Org: User:
Start: 06/30/07 End: 02/29/08 Due: 02/28/09

Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-menopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT00322348 Org: User:
Start: 04/30/06 End: 11/30/09 Due: 11/30/10

A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD9567.

Phase: N/A Priority: Normal
NCT ID: NCT02512575 Org: User:
Start: 11/18/15 End: 09/26/16 Due: 09/26/17

An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients

Phase: N/A Priority: Normal
NCT ID: NCT00352261 Org: User:
Start: 01/31/06 End: 04/30/07 Due: 04/30/08

Real-world Study Assessing Efficacy of TezepeLumaB in Patients With Severe Asthma Regardless of Phenotype in Russia

Phase: N/A Priority: Normal
NCT ID: NCT06566885 Org: User:
Start: 09/10/24 End: 06/30/26 Due: 06/30/27

An Intermediate Access Protocol for Selumetinib for Treatment of Neurofibromatosis Type 1

Phase: N/A Priority: Normal
NCT ID: NCT03259633 Org: User:
Start: - End: - Due: -

GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00226330 Org: User:
Start: 03/31/05 End: 12/31/06 Due: 12/31/07

Study to Determine the Effect of Food on the Blood Levels of AZD9291 Following Oral Dosing of a Tablet Formulation in Patients With Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02163733 Org: User:
Start: 11/14/14 End: 01/24/23 Due: 01/24/24

Metabolic Changes in Prostate Cancer Patients With Androgen-ablation Therapy (AAT)

Phase: N/A Priority: Normal
NCT ID: NCT01284608 Org: User:
Start: 03/31/11 End: 12/31/12 Due: 12/31/13

Observational Study to Evaluate Efficacy and Remission Status for Schizophrenia Patients Under Atypical Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00809731 Org: User:
Start: 12/31/08 End: 09/30/10 Due: 09/30/11

Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour

Phase: N/A Priority: Normal
NCT ID: NCT00503204 Org: User:
Start: 09/30/07 End: 12/31/08 Due: 12/31/09